French group Sanofi to buy U.S. firm Principia Biopharma for $3.7 billion

PARIS French healthcare company Sanofi SA has agreed to buy U.S. company Principia Biopharma Inc for around $3.7 billion, the companies said on Monday, strengthening Sanofi’s presence in research and development (R&D) areas.

Sanofi will buy the outstanding shares of Principia for $100 per share in cash, according to the joint statement, representing an aggregate equity value of around $3.68 billion on a fully diluted basis and a premium of 10% to Principia Biopharma’s stock closing of $90.74 on Aug. 14.

Sanofi said the acquisition of Principia Biopharma, which develops therapies for serious immune diseases, would strengthen its research capabilities in areas such as autoimmune and allergic diseases.

“This acquisition advances our ongoing R&D transformation to accelerate development of the most promising medicines that will address significant patient needs,” said Sanofi Chief Executive Officer Paul Hudson.

Sanofi said it expected to complete the acquisition of Principia Biopharma in the fourth quarter of 2020. 

“The merger will provide global resources to get these novel therapies to patients faster,” said Martin Babler, president and chief executive officer at Principia Biopharma.

Also Watch

Facebook Politics: Rahul Slams BJP For ‘Influencing Electorate’; BJP Hits Back With Fake News Charge

The acquisition of Principia Biopharma marks the latest large-scale takeover of rivals by Sanofi, following Sanofi’s 2018 takeover of U.S. haemophilia treatment specialist Bioverativ for $11.6 billion, and its purchase of biotechnology company Synthorx in December 2019 for around $2.5 billion.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor


Array
(
[videos] => Array
(
[0] => Array
(
[id] => 5f3a1c69046bae25c91df2dd
[youtube_id] => yKdbRNmDiOY
French group Sanofi to buy U.S. firm Principia Biopharma for $3.7 billion => Facebook Politics: Rahul Slams BJP For ‘Influencing Electorate’; BJP Hits Back With Fake News Charge
)

[1] => Array
(
[id] => 5f3a1999a07a3a25bbc20973
[youtube_id] => iYP9AfkYHVY
French group Sanofi to buy U.S. firm Principia Biopharma for $3.7 billion => 1 Year Wait Ends, 4G Services Restored In 2 J&K Districts, Residents Welcome Move | CNN News18
)

)

[query] => https://pubstack.nw18.com/pubsync/v1/api/videos/recommended?source=n18english&channels=5d95e6c378c2f2492e2148a2,5d95e6c278c2f2492e214884,5d96f74de3f5f312274ca307&categories=5d95e6d7340a9e4981b2e10a&publish_min=2020-08-14T11:28:03.000Z&publish_max=2020-08-17T11:28:03.000Z&sort_by=date-relevance&order_by=0&limit=2
)

Speak Your Mind

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get in Touch

350FansLike
100FollowersFollow
281FollowersFollow
150FollowersFollow

Recommend for You

Oh hi there 👋
It’s nice to meet you.

Subscribe and receive our weekly newsletter packed with awesome articles that really matters to you!

We don’t spam! Read our privacy policy for more info.

You might also like

Watch: How to Cut Costs and Find Funding in...

During a financial downturn, keeping your company in business can come down to one...

Barr Claims ‘Numerous Reports’ Of Agitators Flying Into D.C....

TOPLINE  Attorney General Bill Bar claimed in a CNN interview on Wednesday to have...

CDC: 19% Of Americans Have Put Bleach On Food...

If you read the labels on Clorox bleach, they...

Shape And Hold: How A British Entrepreneur Took On...

“Just keep going.” That’s Paul Adrian’s advice to fellow entrepreneurs. The prominent successes of...